PACB Pacific Biosciences of California, Inc. - Common Stock
$1,23
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$1–$3
10% of range
Ocena Analityków
BUY
14 analysts
Cena Docelowa
$2
+86% upside
P/E (TTM)
-0.7
ROE
-1634.9%
Marża Zysku Netto
-341.5%
O Pacific Biosciences of California, Inc. - Common Stock Przegląd firmy z Wikipedii
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
Czytaj więcej
Pacific Biosciences of California, Inc. (a.k.a. PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
History
The company was founded based on research done at Cornell University that combined semiconductor processing and photonics with biotechnology research. Three graduate students in the lab of Professors Watt W. Webb — Jonas Korlach — and Harold Craighead — Steve Turner and Mathieu Foquet — became the first employees.
It began under the name Nanofluidics, Inc. The company raised nearly US$400,000,000 in six rounds of primarily venture capital financing, making it one of the most capitalized startups in 2010 leading up to their public offering in October of that year. Key investors included Mohr Davidow Ventures, Kleiner, Perkins, Caufield & Byers, Alloy Ventures, and Wellcome Trust.
The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013.
Leadership
In 2004, Kleiner Perkins entrepreneur-in-residence Hugh Martin became CEO. On 6 January 2012 board member Michael Hunkapiller, PhD assumed the role of CEO. Hunkapiller retired in September 2020, and was replaced by chairman of the board Christian Henry. Henry was a former executive VP and chief commercial officer of Illumina before joining the board at PacBio in July 2018.
Illumina: attempted acquisition
On 1 November 2018, Illumina, Inc. agreed to purchase PacBio for US$1.2 billion in cash. The deal was expected to close in the fourth quarter of 2019. In December 2019, the Federal Trade Commission sued to block the acquisition. The deal was abandoned with an announcement on 2 January 2020. Illumina further agreed to pay Pacific Biosciences a $98 million US termination fee plus previously agreed upon deal extension payments of $22 million US in February and $6 million US in March 2020.
Sequencing technology
Sequencing instruments
The company's first scientific instrument, called the PacBio RS, was released to a limited set of customers in late 2010., with full commercial release in early 2011. Sequencing provider GATC Biotech was selected by Pacific Biosciences as its first European service provider in late 2010. A new version of the sequencer was released in April 2013 it produced longer sequence reads and higher throughput than the original RS instrument. The RS instrument will officially be supported until the end of 2021. In September 2015, the company released a new sequencing instrument, the Sequel System, with increased sequencing capacity at a smaller size and lower price compared to the PacBio RS II. Subsequently, in October 2022, PacBio launched a new sequencing system, which can sequence 1,300 human genomes per year as compared to 86 per year of the previous PacBio sequencing machines.
Reagents and SMRT Cells
To use either instrument, customers must also purchase reagent packs for DNA preparation and sequencing and small consumables called "SMRT Cells." Cells for early forms of the sequencer are slightly less than one-centimeter square and contains tens of thousands of zero-mode waveguides, whereas newer systems have a higher density of cells and contain 25 million zero-mode waveguides (ZMWGs), allowing for faster DNA sequencing.
Software and applications
Their secondary analysis bioinformatics product for the RS, called “SMRT Analysis”, was open source. For the Sequel system the secondary analysis software was reorganized as the "SMRT Link" application. In 2013, the company released new bioinformatics tools for automated genome assembly (HGAP) and finishing (Quiver).
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
PACB Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.23
Kapitalizacja Rynkowa
$382M
P/E (TTM)
-0.7
EPS (TTM)
$-1.82
Przychody (TTM)
$160M
Stopa dywidendy
—
ROE
-1634.9%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$1 – $3
PACB Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$160M
2016-12-31
→
2025-12-31
EPS
$-1.82
2018-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-114M
2016-12-31
→
2025-12-31
Marże
-341.5%
2016-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
PACB
Mediana porównawcza
P/E (TTM)
-0.7
17.5
P/S (TTM)
2.4
3.3
P/B
71.5
2.1
Price / FCF (Cena / FCF)
-3.4
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
PACB
Mediana porównawcza
Gross Margin (Marża brutto)
28.6%
42.5%
Operating Margin (Marża Operacyjna)
-346.1%
—
Net Profit Margin (Marża Zysku Netto)
-341.5%
-56.5%
ROA
-53.4%
-17.2%
ROE
-1634.9%
-41.3%
ROIC
-10360.5%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
PACB
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5.1
4.9
Quick Ratio (Wskaźnik Szybkości)
4.3
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
PACB
Mediana porównawcza
Revenue YoY (Przychody R/R)
3.9%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
7.6%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
15.2%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
PACB
Mediana porównawcza
PACB Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
14 analityków
- Mocne kupno 4 28,6%
- Kup 5 35,7%
- Trzymaj 4 28,6%
- Sprzedaj 1 7,1%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
6 analityków · 2026-08-14
Mediana
$2.50
Średnia
$2.29
← Poniżej wszystkich celów
$1.23
Niski
$1.25
Wysoki
$3.00
Średni cel
$2.50
+103,0%
Średnia cel
$2.29
+86,1%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-0.19%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.14 | $-0.13 | -0.01% |
| 31 marca 2026 | $-0.12 | $-0.14 | 0.02% |
| 31 grudnia 2025 | $-0.12 | $-0.15 | 0.03% |
| 30 września 2025 | $-0.13 | $-0.15 | 0.03% |
| 30 czerwca 2025 | $-0.14 | $-0.17 | 0.03% |
| 31 marca 2025 | $-1.44 | $-0.19 | -1.2% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | — | — | — | — | — | — |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | — |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
| LFCR | $249M | -5.3 | 0.47% | -30.0% | -461.3% | 31.3% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | — |
| QSI | — | — | — | — | — | — |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $160M | $154M | $201M | $128M | $131M | $79M | $91M | $79M | $93M | $91M | $93M | $61M | |
| Cost of Revenue | $114M | $117M | $148M | $79M | $72M | $46M | $56M | $54M | $59M | $47M | $39M | $37M | |
| Gross Profit | $46M | $37M | $53M | $49M | $59M | $33M | $35M | $25M | $35M | $44M | $53M | $23M | |
| R&D Expense | $97M | $135M | $187M | $193M | $113M | $64M | $60M | $63M | $65M | $68M | $60M | $48M | |
| SG&A Expense | $141M | $175M | $170M | $161M | $124M | $73M | $75M | $63M | $59M | $48M | $45M | $38M | |
| Operating Expenses | $600M | $512M | $387M | $356M | $269M | $137M | $135M | $126M | $124M | $115M | $83M | $86M | |
| Operating Income | $-554M | $-474M | $-334M | $-307M | $-210M | $-104M | $-101M | $-101M | $-90M | $-71M | $-29M | $-63M | |
| Interest Expense | · | · | $14M | $15M | $13M | $267.0K | $3M | $2M | $3M | $3M | $3M | $3M | |
| Other Non-op | $15M | $24M | $33M | $8M | $93.0K | $2M | $1M | $848.0K | $516.0K | $103.0K | $364.0K | $-478.0K | |
| Pretax Income | $-546M | $-310M | $-318M | $-314M | $-275M | $29M | $-84M | · | · | · | · | · | |
| Income Tax | $318.0K | $316.0K | $-11M | $0 | $-94M | · | · | · | · | · | · | · | |
| Net Income | $-546M | $-310M | $-307M | $-314M | $-181M | $29M | $-84M | $-103M | $-92M | $-74M | $-32M | $-66M | |
| EPS (Basic) | $-1.82 | $-1.13 | $-1.21 | $-1.40 | $-0.89 | $0.18 | $-0.55 | $-0.76 | · | · | · | · | |
| EPS (Diluted) | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 | $0.17 | $-0.55 | $-0.76 | · | · | · | · | |
| Shares (Basic) | 299,959,000 | 274,488,000 | 253,629,000 | 224,550,000 | 204,136,000 | 165,187,000 | 152,527,000 | 135,094,000 | · | · | · | · | |
| Shares (Diluted) | 299,959,000 | 288,366,000 | 253,629,000 | 224,550,000 | 204,136,000 | 174,970,000 | 152,527,000 | 135,094,000 | · | · | · | · | |
| EBITDA | $-554M | $-474M | $-334M | $-307M | $-210M | $-104M | $-101M | $-94M | $-81M | $-67M | $-25M | $-59M |
Bilans 30
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $55M | $180M | $325M | $461M | $82M | $30M | $19M | $17M | $17M | $34M | $36M | |
| Short-term Investments | $216M | $335M | $452M | $447M | $584M | $237M | $19M | $84M | $46M | $55M | $49M | $65M | |
| Receivables | $35M | $28M | $37M | $19M | $24M | $17M | $15M | $9M | $13M | $11M | $5M | $3M | |
| Inventory | $49M | $59M | $57M | $50M | $25M | $14M | $13M | $18M | $23M | $16M | $11M | $11M | |
| Prepaid Expense | $11M | $19M | $17M | $10M | $7M | $5M | $3M | $3M | $2M | $10M | $12M | $2M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $931.0K | $476.0K | $741.0K | $107.0K | |
| Current Assets | $375M | $496M | $742M | $852M | $1.10B | $356M | $81M | $132M | $102M | $109M | $111M | $118M | |
| PP&E (Net) | $24M | $31M | $36M | $42M | $33M | $25M | $30M | $34M | $38M | $15M | $9M | $7M | |
| PP&E (Gross) | $117M | $112M | $111M | $107M | $89M | $75M | $74M | $71M | $70M | $52M | $42M | $37M | |
| Accum. Depreciation | $92M | $82M | $75M | $65M | $56M | $50M | $44M | $37M | $32M | $37M | $34M | $30M | |
| Goodwill | $318M | $318M | $462M | $410M | $410M | · | · | · | · | · | · | · | |
| Intangibles | $15M | $390M | $457M | $410M | $411M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $9M | $9M | $13M | $11M | $1M | $43.0K | $42.0K | $43.0K | $45.0K | $10M | $8M | $29.0K | |
| Total Assets | $784M | $1.26B | $1.75B | $1.77B | $2.01B | $414M | $148M | $170M | $144M | $138M | $131M | $124M | |
| Accounts Payable | $21M | $17M | $15M | $12M | $11M | $4M | $8M | $7M | $9M | $8M | $5M | $6M | |
| Accrued Liabilities | $34M | $23M | $46M | $33M | $36M | $17M | $13M | $13M | $13M | $17M | $16M | $11M | |
| Short-term Debt | · | $0 | $490.0K | $2M | $2M | · | $16M | · | · | · | · | · | |
| Current Liabilities | $73M | $66M | $95M | $263M | $72M | $39M | $49M | $27M | $29M | $34M | $38M | $31M | |
| Capital Leases | $57M | $15M | $32M | $41M | $50M | $38M | $42M | · | · | · | · | $2M | |
| Other Non-current Liabilities | $0 | $546.0K | $751.0K | $1M | $3M | $752.0K | · | · | · | $2M | $1M | $2M | |
| Total Liabilities | $779M | $754M | $1.04B | $1.20B | $1.22B | $78M | $93M | $56M | $58M | $53M | $58M | $69M | |
| Long-term Debt | · | · | · | $897M | $896M | · | $16M | $15M | $14M | $16M | · | $14M | |
| Total Debt | · | $0 | $490.0K | $2M | $2M | · | $16M | · | · | · | · | · | |
| Common Stock | $302.0K | $294.0K | $268.0K | $227.0K | $221.0K | $192.0K | $153.0K | $150.0K | $116.0K | $93.0K | $80.0K | $74.0K | |
| Paid-in Capital | $2.70B | $2.65B | $2.54B | $2.10B | $2.01B | $1.37B | $1.12B | $1.10B | $966M | $872M | $787M | $736M | |
| Retained Earnings | $-2.70B | $-2.15B | $-1.84B | $-1.53B | $-1.22B | $-1.04B | $-1.07B | $-982M | $-880M | $-788M | $-713M | $-681M | |
| AOCI | $457.0K | $422.0K | $219.0K | $-5M | $-1M | $85.0K | $5.0K | $-36.0K | $-32.0K | $5.0K | $-7.0K | $9.0K | |
| Stockholders' Equity | $5M | $507M | $701M | $563M | $791M | $335M | $55M | $114M | $86M | $85M | $74M | $55M | |
| Liabilities + Equity | $784M | $1.26B | $1.75B | $1.77B | $2.01B | $414M | $148M | $170M | $144M | $138M | $131M | $124M | |
| Shares Outstanding | 301,956,000 | 294,418,000 | 267,744,000 | 226,505,000 | 220,978,000 | 192,294,000 | 153,119,000 | 150,244,000 | 116,277,000 | 92,677,000 | 79,983,000 | 73,927,000 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $7M | $8M | $4M | $4M | $4M | |
| Stock-based Comp | $42M | $71M | $72M | $79M | $73M | $18M | $16M | $23M | $20M | $20M | $14M | $10M | |
| Deferred Tax | $-546.0K | $-205.0K | $-11M | $0 | $-94M | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $369M | $27M | $8M | $913.0K | $0 | $0 | $0 | · | · | · | · | · | |
| Restructuring | · | $13M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | $6M | $-4M | $-17M | $-34M | $528.0K | |
| Operating Cash Flow | $-111M | $-206M | $-259M | $-263M | $-111M | $20M | $-78M | $-66M | $-68M | $-68M | $-48M | $-51M | |
| CapEx | $3M | $6M | $9M | $17M | $6M | $1M | $3M | $2M | $10M | $8M | $3M | $2M | |
| Investing Cash Flow | $115M | $124M | $5M | $116M | $-679M | $-219M | $62M | $-38M | $-2M | $-15M | · | · | |
| Stock Issued | $0 | $0 | $189M | $0 | $32M | $46M | $9M | $10M | $9M | $8M | $7M | $4M | |
| Net Stock Activity | $0 | $0 | $15M | $11M | $32M | $46M | $9M | $10M | $9M | $8M | $7M | $4M | |
| Financing Cash Flow | $3M | $-43M | $109M | $10M | $1.17B | $252M | $27M | $107M | $69M | $66M | · | · | |
| Net Change in Cash | $8M | $-125M | $-146M | $-138M | $380M | · | · | · | $-258.0K | $-17M | $-3M | $10M | |
| Taxes Paid | $481.0K | $256.0K | $140.0K | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-114M | $-212M | $-268M | $-280M | $-117M | $18M | $-81M | $-68M | $-78M | $-76M | $-51M | $-53M | |
| Levered FCF | · | · | $-282M | · | $-125M | · | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.6% | 24.2% | 26.3% | 38.2% | 45.1% | 41.3% | 38.0% | 31.9% | 37.1% | 48.7% | 57.6% | 38.6% | |
| Operating Margin | -346.1% | -308.0% | -166.8% | -239.4% | -161.2% | -132.3% | -110.6% | -128.4% | -96.1% | -78.5% | -31.4% | -103.7% | |
| Net Margin | -341.5% | -201.2% | -153.0% | -244.9% | -138.8% | 37.3% | -92.6% | -130.4% | -98.6% | -82.0% | -34.2% | -109.2% | |
| Pretax Margin | -341.3% | -201.0% | -158.7% | -244.9% | -210.6% | · | · | · | · | · | · | · | |
| EBITDA Margin | -346.1% | -308.0% | -166.8% | -239.4% | -161.2% | -132.3% | -110.6% | -119.3% | -87.0% | -74.3% | -27.4% | -96.8% | |
| ROA | -53.4% | -20.6% | -17.5% | -16.7% | -15.0% | 10.5% | -52.9% | -65.2% | -65.4% | -55.3% | -24.8% | -50.7% | |
| ROE | -1634.9% | -64.6% | -41.9% | -52.8% | -22.2% | 12.7% | -158.8% | -83.4% | -108.0% | -94.0% | -49.3% | -106.6% | |
| ROIC | -10360.5% | -93.7% | -46.0% | · | -17.5% | · | · | · | · | · | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.1 | 7.5 | 7.8 | 3.2 | 15.4 | 9.2 | 1.6 | 4.9 | 3.5 | 3.2 | 2.9 | 3.7 | |
| Quick Ratio | 4.3 | 6.3 | 7.0 | 3.0 | 14.9 | 8.7 | 1.3 | 4.1 | 2.7 | 2.5 | 2.3 | 3.3 | |
| Debt / Equity | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.3 | · | · | · | · | · | |
| Interest Coverage | · | · | -23.3 | -20.9 | -16.8 | -391.0 | -38.5 | -41.7 | -30.7 | -22.0 | -10.0 | -22.2 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.6 | 0.5 | 0.7 | 0.7 | 0.7 | 0.5 | |
| Inventory Turnover | 2.1 | 2.0 | 2.8 | 2.1 | 3.7 | 3.4 | 3.6 | 2.6 | 3.0 | 3.5 | 3.5 | 3.5 | |
| Receivables Turnover | 5.1 | 4.8 | 7.2 | 6.0 | 6.4 | 4.9 | 7.6 | 7.1 | 7.5 | 10.9 | 21.4 | 19.7 |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 3.9% | -23.2% | 56.3% | -1.7% | 65.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 5.7% | 36.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 15.2% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $160M | $154M | $201M | $128M | $131M | $79M | $91M | $79M | $93M | $91M | $93M | $61M | |
| Net Income TTM | $-546M | $-310M | $-307M | $-314M | $-181M | $29M | $-84M | $-103M | $-92M | $-74M | $-32M | $-66M | |
| Market Cap | $565M | $539M | $2.63B | $1.85B | $4.52B | $4.99B | $787M | $1.11B | $307M | $352M | $1.05B | $580M | |
| Enterprise Value | · | $149M | $2.00B | $1.08B | $3.48B | · | $754M | · | · | · | · | · | |
| P/E | -1.0 | -1.2 | -8.1 | -5.8 | -23.0 | 152.6 | -9.3 | -9.7 | · | · | · | · | |
| P/S | 3.5 | 3.5 | 13.1 | 14.4 | 34.6 | 63.2 | 8.7 | 14.1 | 3.3 | 3.9 | 11.3 | 9.6 | |
| P/B | 105.6 | 1.1 | 3.7 | 3.3 | 5.7 | 14.9 | 14.3 | 9.7 | 3.6 | 4.2 | 14.3 | 10.5 | |
| P / Tangible Book | · | · | · | · | · | 14.9 | · | · | · | · | · | · | |
| P / Cash Flow | -5.1 | -2.6 | -10.1 | -7.0 | -40.7 | 255.8 | -10.0 | -16.7 | -4.5 | -5.2 | -21.9 | -11.3 | |
| P / FCF | -5.0 | -2.5 | -9.8 | -6.6 | -38.6 | 270.2 | -9.7 | -16.3 | -3.9 | -4.6 | -20.6 | -10.9 | |
| EV / EBITDA | · | -0.3 | -6.0 | -3.5 | -16.5 | · | -7.5 | · | · | · | · | · | |
| EV / FCF | · | -0.7 | -7.4 | -3.9 | -29.7 | · | -9.3 | · | · | · | · | · | |
| EV / Revenue | · | 1.0 | 10.0 | 8.4 | 26.7 | · | 8.3 | · | · | · | · | · | |
| Earnings Yield | -97.3% | -86.9% | -12.3% | -17.1% | -4.3% | 0.66% | -10.7% | -10.3% | · | · | · | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $37M | $45M | $38M | $40M | $37M | $39M | $40M | $36M | $39M | $58M | $56M | $48M | $39M | $27M | $32M | |
| Cost of Revenue | $26M | $24M | $28M | $23M | $25M | $39M | $29M | $30M | $30M | $28M | $49M | $38M | $32M | $29M | $22M | $19M | |
| Gross Profit | $13M | $13M | $17M | $16M | $15M | $-1M | $10M | $10M | $6M | $11M | $10M | $18M | $16M | $10M | $5M | $14M | |
| R&D Expense | $23M | $20M | $23M | $23M | $23M | $29M | $27M | $26M | $38M | $43M | $45M | $48M | $46M | $49M | $43M | $47M | |
| SG&A Expense | $33M | $31M | $34M | $31M | $36M | $40M | $42M | $44M | $46M | $44M | $46M | $43M | $41M | $40M | $45M | $37M | |
| Operating Expenses | $57M | $21M | $58M | $55M | $60M | $428M | $163M | $74M | $182M | $93M | $97M | $100M | $89M | $101M | $92M | $88M | |
| Operating Income | $-45M | $-8M | $-41M | $-39M | $-45M | $-429M | $-153M | $-64M | $-176M | $-81M | $-88M | $-82M | $-73M | $-91M | $-87M | $-75M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $4M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-op | $2M | $2M | $3M | $3M | $5M | $4M | $4M | $7M | $6M | $7M | $8M | $9M | $9M | $7M | $6M | $1M | |
| Pretax Income | $-45M | $-8M | $-40M | $-38M | $-42M | $-426M | $3M | $-61M | $-173M | $-78M | $-83M | $-78M | $-70M | $-88M | $-84M | $-77M | |
| Income Tax | $58.0K | $184.0K | $202.0K | $383.0K | $35.0K | $-302.0K | $316.0K | $0 | $0 | $0 | $-718.0K | $-11M | $0 | $0 | $0 | $0 | |
| Net Income | $-45M | $-8M | $-40M | $-38M | $-42M | $-426M | $2M | $-61M | $-173M | $-78M | $-82M | $-67M | $-70M | $-88M | $-84M | $-77M | |
| EPS (Basic) | $-0.14 | $-0.03 | $-0.11 | $-0.13 | $-0.14 | $-1.44 | $0.02 | $-0.22 | $-0.64 | $-0.29 | $-0.31 | $-0.26 | $-0.28 | $-0.36 | $-0.37 | $-0.34 | |
| EPS (Diluted) | $-0.14 | $-0.03 | $-0.11 | $-0.13 | $-0.14 | $-1.44 | $-0.44 | $-0.22 | $-0.64 | $-0.29 | $-0.31 | $-0.26 | $-0.28 | $-0.36 | $-0.37 | $-0.34 | |
| Shares (Basic) | 310,655,000 | 305,819,000 | -597,905,000 | 300,844,000 | 300,162,000 | 296,858,000 | -540,390,000 | 272,915,000 | 272,385,000 | 269,578,000 | -493,474,000 | 255,001,000 | 250,070,000 | 242,032,000 | -447,361,000 | 225,123,000 | |
| Shares (Diluted) | 310,655,000 | 305,819,000 | -597,905,000 | 300,844,000 | 300,162,000 | 296,858,000 | -526,512,000 | 272,915,000 | 272,385,000 | 269,578,000 | -493,474,000 | 255,001,000 | 250,070,000 | 242,032,000 | -447,361,000 | 225,123,000 | |
| EBITDA | $-45M | $-8M | · | $-39M | $-45M | $-429M | · | $-64M | $-176M | $-81M | · | $-82M | $-73M | $-91M | · | $-75M |
Bilans 27
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61M | $56M | $64M | $56M | $55M | $59M | $55M | $78M | $100M | $77M | $180M | $386M | $209M | $354M | $325M | $304M | |
| Short-term Investments | $176M | $220M | $216M | $242M | $260M | $285M | $335M | $393M | $410M | $485M | · | $382M | $621M | $521M | · | $530M | |
| Receivables | $31M | $29M | $35M | $31M | $32M | $32M | $28M | $29M | $32M | $30M | · | $30M | $24M | $30M | · | $23M | |
| Inventory | $61M | $51M | $49M | $53M | $54M | $54M | $59M | $66M | $69M | $67M | · | $68M | $68M | $62M | · | $43M | |
| Prepaid Expense | $10M | $13M | $11M | $12M | $12M | $15M | $19M | $17M | $17M | $17M | · | $15M | $14M | $14M | · | $13M | |
| Current Assets | $339M | $370M | $375M | $394M | $413M | $445M | $496M | $584M | $628M | $677M | · | $882M | $936M | $981M | · | $914M | |
| PP&E (Net) | $27M | $24M | $24M | $22M | $23M | $25M | $31M | $32M | $35M | $37M | · | $40M | $40M | $41M | · | $39M | |
| PP&E (Gross) | · | · | $117M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $92M | · | · | · | $82M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $318M | $318M | $318M | $318M | $318M | $318M | $318M | $369M | $369M | $462M | · | $464M | $410M | $410M | · | $410M | |
| Intangibles | $13M | $14M | $15M | $16M | $17M | $18M | $390M | $436M | $443M | $450M | · | $462M | $410M | $410M | · | $410M | |
| Other Non-current Assets | $13M | $14M | $9M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | · | $13M | $13M | $13M | · | $1M | |
| Total Assets | $752M | $782M | $784M | $803M | $825M | $861M | $1.26B | $1.45B | $1.51B | $1.67B | · | $1.90B | $1.85B | $1.90B | · | $1.82B | |
| Accounts Payable | $19M | $14M | $21M | $16M | $15M | $14M | $17M | $12M | $17M | $21M | · | $16M | $17M | $17M | · | $13M | |
| Accrued Liabilities | $30M | $34M | $34M | $29M | $27M | $29M | $23M | $19M | $22M | $22M | · | $35M | $27M | $19M | · | $25M | |
| Current Liabilities | $69M | $65M | $73M | $63M | $60M | $67M | $66M | $60M | $78M | $73M | · | $184M | $271M | $266M | · | $82M | |
| Capital Leases | $60M | $59M | $57M | $54M | $52M | $50M | $15M | $17M | $20M | $29M | · | $34M | $37M | $39M | · | $43M | |
| Other Non-current Liabilities | $8M | $8M | $0 | $0 | $0 | $0 | $546.0K | $751.0K | $751.0K | $751.0K | · | $1M | $837.0K | $969.0K | · | $2M | |
| Total Liabilities | $785M | $780M | $779M | $767M | $764M | $769M | $754M | $997M | $1.02B | $1.02B | · | $1.13B | $1.21B | $1.20B | · | $1.19B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $897M | · | $897M | |
| Common Stock | $311.0K | $311.0K | $302.0K | $302.0K | $300.0K | $300.0K | $294.0K | $274.0K | $272.0K | $272.0K | · | $258.0K | $250.0K | $250.0K | · | $226.0K | |
| Paid-in Capital | $2.72B | $2.71B | $2.70B | $2.69B | $2.68B | $2.67B | $2.65B | $2.60B | $2.58B | $2.57B | · | $2.52B | $2.33B | $2.31B | · | $2.08B | |
| Retained Earnings | $-2.75B | $-2.70B | $-2.70B | $-2.65B | $-2.62B | $-2.58B | $-2.15B | $-2.15B | $-2.09B | $-1.92B | · | $-1.76B | $-1.69B | $-1.62B | · | $-1.45B | |
| AOCI | $-503.0K | $-147.0K | $457.0K | $415.0K | $267.0K | $381.0K | $422.0K | $2M | $-523.0K | $-306.0K | · | $-2M | $-3M | $-2M | · | $-6M | |
| Stockholders' Equity | $-33M | $2M | $5M | $36M | $61M | $92M | $507M | $453M | $493M | $649M | $701M | $764M | $642M | $692M | $563M | $627M | |
| Liabilities + Equity | $752M | $782M | $784M | $803M | $825M | $861M | $1.26B | $1.45B | $1.51B | $1.67B | · | $1.90B | $1.85B | $1.90B | · | $1.82B | |
| Shares Outstanding | 310,810,000 | 310,487,000 | 301,956,000 | 301,853,000 | 300,350,000 | 300,041,000 | 294,418,000 | 273,812,000 | 272,491,000 | 272,280,000 | 267,744,000 | 258,374,000 | 250,473,000 | 249,803,000 | 226,505,000 | 225,916,000 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $4M | $10M | $11M | $12M | $9M | $16M | $18M | $17M | $20M | $17M | $20M | $18M | $18M | $18M | $19M | |
| Amort. of Intangibles | · | $1M | $1M | $1M | $1M | $366M | $7M | $7M | $7M | $7M | $7M | $942.0K | $232.0K | $234.0K | $228.0K | $229.0K | |
| Restructuring | · | · | · | · | · | · | · | · | $11M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-36M | $-45M | $-19M | $-19M | $-29M | $-44M | $-31M | $-45M | $-54M | $-76M | $-58M | $-65M | $-42M | $-95M | $-61M | $-63M | |
| CapEx | $2M | $3M | $861.0K | $-86.0K | $550.0K | $1M | $2M | $-787.0K | $1M | $4M | $2M | $830.0K | $2M | $4M | $5M | $4M | |
| Investing Cash Flow | $40M | $36M | $26M | $19M | $25M | $45M | $58M | $23M | $77M | $-34M | $-67M | $242M | $-99M | $-73M | $80M | $54M | |
| Stock Issued | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $189M | $0 | $-6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $189M | · | · | |
| Financing Cash Flow | $255.0K | $1M | $0 | $1M | $0 | $2M | $-50M | $812.0K | $-152.0K | $7M | $-82M | $-781.0K | $-5M | $196M | $819.0K | $3M | |
| Net Change in Cash | $5M | $-7M | $7M | $2M | $-4M | $3M | $-23M | $-22M | $22M | $-103M | $-206M | $176M | $-145M | $29M | $21M | $-6M | |
| Free Cash Flow | · | $-48M | · | · | · | $-45M | · | · | · | $-80M | · | · | · | $-98M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-83M | · | · | · | $-102M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.4% | 34.5% | · | 41.4% | 36.9% | -3.7% | · | 25.0% | 16.5% | 29.1% | · | 32.1% | 32.7% | 25.1% | · | 41.9% | |
| Operating Margin | -114.4% | -22.5% | · | -101.1% | -112.8% | -1154.5% | · | -160.3% | -488.3% | -209.6% | · | -148.1% | -153.8% | -234.6% | · | -230.9% | |
| Net Margin | -114.7% | -22.3% | · | -98.9% | -105.4% | -1146.8% | · | -151.9% | -481.3% | -201.4% | · | -120.1% | -146.8% | -226.3% | · | -238.2% | |
| Pretax Margin | -114.5% | -21.8% | · | -97.9% | -105.4% | -1147.6% | · | -151.9% | -481.3% | -201.4% | · | -139.3% | -146.8% | -226.3% | · | -238.2% | |
| EBITDA Margin | -114.4% | -22.5% | · | -101.1% | -112.8% | -1154.5% | · | -160.3% | -488.3% | -209.6% | · | -148.1% | -153.8% | -234.6% | · | -230.9% | |
| ROA | -5.7% | -1.0% | · | -3.4% | -3.6% | -33.7% | · | -3.6% | -10.3% | -4.4% | · | -3.6% | -3.8% | -4.6% | · | -4.0% | |
| ROE | -316.5% | -17.6% | · | -15.5% | -15.1% | -115.1% | · | -10.0% | -30.6% | -11.7% | · | -9.6% | -10.5% | -12.3% | · | -10.5% | |
| ROIC | 134.5% | -361.2% | · | -108.8% | -73.0% | -467.7% | · | -14.1% | -35.7% | -12.5% | · | -9.3% | -11.4% | -13.2% | · | · |
Płynność i wypłacalność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 5.7 | · | 6.2 | 6.9 | 6.7 | · | 9.7 | 8.0 | 9.3 | · | 4.8 | 3.4 | 3.7 | · | 11.2 | |
| Quick Ratio | 3.9 | 4.7 | · | 5.2 | 5.8 | 5.6 | · | 8.3 | 6.9 | 8.1 | · | 4.3 | 3.1 | 3.4 | · | 10.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -22.8 | · | -23.0 | -20.6 | -25.1 | · | -20.4 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 2.1 | 1.9 | 1.4 | · | 1.4 |
Wycena (TTM) 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $154M | $153M | · | $155M | $153M | $152M | · | $170M | $178M | $181M | · | $174M | $154M | $140M | · | $136M | |
| Net Income TTM | $-133M | $-514M | · | $-567M | $-702M | $-738M | · | $-379M | $-388M | $-303M | · | $-302M | $-306M | $-318M | · | $-213M | |
| Market Cap | $522M | $410M | · | $386M | $372M | $354M | · | $465M | $373M | $1.02B | · | $2.16B | $3.33B | $2.89B | · | $1.31B | |
| P/E | -3.8 | -0.8 | · | -0.7 | -0.5 | -0.5 | · | -1.2 | -0.9 | -3.2 | · | -6.7 | -10.2 | -8.3 | · | -6.1 | |
| P/S | 3.4 | 2.7 | · | 2.5 | 2.4 | 2.3 | · | 2.7 | 2.1 | 5.6 | · | 12.4 | 21.6 | 20.7 | · | 9.7 | |
| P/B | -15.7 | 173.2 | · | 10.7 | 6.1 | 3.9 | · | 1.0 | 0.8 | 1.6 | · | 2.8 | 5.2 | 4.2 | · | 2.1 | |
| P / Cash Flow | · | -9.2 | · | · | · | -8.0 | · | · | · | -13.5 | · | · | · | -30.5 | · | · | |
| P / FCF | · | -8.6 | · | · | · | -7.8 | · | · | · | -12.8 | · | · | · | -29.4 | · | · | |
| Earnings Yield | -26.2% | -131.8% | · | -150.8% | -196.8% | -219.5% | · | -82.9% | -107.3% | -31.7% | · | -14.8% | -9.8% | -12.0% | · | -16.4% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $160M | $154M | $201M | $128M | $131M |
| Marża Brutto % | 28.6% | 24.2% | 26.3% | 38.2% | 45.1% |
| Marża Operacyjna % | -346.1% | -308.0% | -166.8% | -239.4% | -161.2% |
| Zysk netto | $-546M | $-310M | $-307M | $-314M | $-181M |
| Rozwodniony EPS | $-1.82 | $-1.59 | $-1.21 | $-1.40 | $-0.89 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Wskaźnik bieżący | 5.1 | 7.5 | 7.8 | 3.2 | 15.4 |
| Wskaźnik Szybkości | 4.3 | 6.3 | 7.0 | 3.0 | 14.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-114M | $-212M | $-268M | $-280M | $-117M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 247 emitentów · $274.5M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 29 (-21 vs poprzedni kw.) | 28 (-2 vs poprzedni kw.) | 65 (+10 vs poprzedni kw.) | 79 (+2 vs poprzedni kw.) | +13.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| ARK Investment Management LLC | $50 032 778 | 29 781 416 | 18,23% | Akcje |
| SOFTBANK GROUP CORP. | $34 358 638 | 20 451 570 | 12,52% | Akcje |
| VANGUARD GROUP INC | $28 083 542 | 15 017 937 | 10,23% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $22 508 529 | 13 397 934 | 8,20% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $10 951 905 | 6 516 920 | 3,99% | Akcje |
| Sumitomo Mitsui Trust Group, Inc. | $10 096 321 | 6 009 715 | 3,68% | Akcje |
| Amova Asset Management Americas, Inc. | $10 036 224 | 6 009 715 | 3,66% | Akcje |
| STATE STREET CORP | $10 014 774 | 5 961 175 | 3,65% | Akcje |
| Point72 Asset Management, L.P. | $8 042 664 | 4 787 300 | 2,93% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $7 127 566 | 4 242 599 | 2,60% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $6 656 903 | 3 962 442 | 2,43% | Akcje |
| Point72 (DIFC) Ltd | $5 465 775 | 4 270 137 | 1,99% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4 488 819 | 2 671 916 | 1,64% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 455 861 | 2 652 298 | 1,62% | Akcje |
| D. E. Shaw & Co., Inc. | $3 959 804 | 2 357 026 | 1,44% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $3 675 213 | 2 187 627 | 1,34% | Akcje |
| Longaeva Partners L.P. | $3 558 628 | 2 118 231 | 1,30% | Akcje |
| GOLDMAN SACHS GROUP INC | $3 262 914 | 1 942 211 | 1,19% | Akcje |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | $2 846 837 | 1 694 546 | 1,04% | Akcje |
| Birchview Capital, LP | $2 268 000 | 1 350 000 | 0,83% | Akcje |
| BlackRock, Inc. | $2 210 561 | 1 315 810 | 0,81% | Akcje |
| BANK OF AMERICA CORP /DE/ | $1 812 811 | 1 079 054 | 0,66% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $1 623 216 | 966 200 | 0,59% | Akcje |
| BOURNE LENT ASSET MANAGEMENT INC | $1 584 332 | 943 055 | 0,58% | Akcje |
| TWO SIGMA ADVISERS, LP | $1 547 425 | 827 500 | 0,56% | Akcje |
| HHLR ADVISORS, LTD. | $1 543 739 | 918 892 | 0,56% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $1 358 616 | 808 700 | 0,49% | Akcje |
| Casdin Capital, LLC | $1 215 929 | 723 767 | 0,44% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $1 150 308 | 684 707 | 0,42% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $1 095 649 | 652 172 | 0,40% | Akcje |
| XTX Topco Ltd | $1 073 322 | 638 882 | 0,39% | Akcje |
| Numerai GP LLC | $1 044 068 | 621 469 | 0,38% | Akcje |
| CARRET ASSET MANAGEMENT, LLC | $1 008 235 | 600 140 | 0,37% | Akcje |
| Man Group plc | $1 003 521 | 597 334 | 0,37% | Akcje |
| Balyasny Asset Management L.P. | $948 090 | 564 339 | 0,35% | Akcje |
| PEAK6 LLC | $933 327 | 555 552 | 0,34% | Akcje |
| Vestmark Advisory Solutions, Inc. | $803 384 | 478 205 | 0,29% | Akcje |
| ArrowMark Colorado Holdings LLC | $786 882 | 468 382 | 0,29% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $741 954 | 441 639 | 0,27% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $673 008 | 400 600 | 0,25% | Opcja sprzedaży |
| RHUMBLINE ADVISERS | $599 738 | 356 996 | 0,22% | Akcje |
| CAXTON ASSOCIATES LP | $577 087 | 315 348 | 0,21% | Akcje |
| Mirador Capital Partners LP | $575 370 | 342 482 | 0,21% | Akcje |
| LPL Financial LLC | $567 003 | 337 502 | 0,21% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $566 071 | 336 947 | 0,21% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $529 407 | 315 123 | 0,19% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $510 919 | 387 060 | 0,19% | Akcje |
| Qube Research & Technologies Ltd | $500 558 | 297 951 | 0,18% | Akcje |
| Nuveen Asset Management, LLC | $494 437 | 270 184 | 0,18% | Akcje |
| GROUP ONE TRADING LLC | $488 645 | 290 860 | 0,18% | Akcje |
| WATER ISLAND CAPITAL LLC | $459 759 | 273 666 | 0,17% | Akcje |
| HSBC HOLDINGS PLC | $457 555 | 277 306 | 0,17% | Akcje |
| BARCLAYS PLC | $447 482 | 266 359 | 0,16% | Akcje |
| WELLS FARGO & COMPANY/MN | $430 196 | 256 069 | 0,16% | Akcje |
| Bank of New York Mellon Corp | $426 179 | 253 678 | 0,16% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $406 056 | 241 700 | 0,15% | Opcja kupna |
| Quadrature Capital Ltd | $311 899 | 185 654 | 0,11% | Akcje |
| Green Alpha Advisors, LLC | $300 140 | 178 655 | 0,11% | Akcje |
| MARSHALL WACE, LLP | $274 919 | 163 642 | 0,10% | Akcje |
| UBS Group AG | $271 868 | 161 826 | 0,10% | Akcje |
| MetLife Investment Management, LLC | $264 093 | 157 198 | 0,10% | Akcje |
| RAYMOND JAMES FINANCIAL INC | $260 524 | 155 074 | 0,09% | Akcje |
| AdvisorNet Financial, Inc | $255 565 | 152 122 | 0,09% | Akcje |
| Main Street Research LLC | $255 528 | 152 100 | 0,09% | Akcje |
| JANE STREET GROUP, LLC | $255 192 | 151 900 | 0,09% | Opcja kupna |
| Voleon Capital Management LP | $226 521 | 134 834 | 0,08% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $223 315 | 132 926 | 0,08% | Akcje |
| IEQ CAPITAL, LLC | $207 954 | 123 782 | 0,08% | Akcje |
| CITIGROUP INC | $206 867 | 123 135 | 0,08% | Akcje |
| Vanguard Global Advisers, LLC | $204 592 | 121 781 | 0,07% | Akcje |
| Koa Wealth Management, LLC | $201 600 | 120 000 | 0,07% | Akcje |
| Invesco Ltd. | $188 456 | 112 176 | 0,07% | Akcje |
| CITADEL ADVISORS LLC | $186 144 | 110 800 | 0,07% | Opcja kupna |
| BENJAMIN EDWARDS INC | $179 922 | 107 153 | 0,07% | Akcje |
| KAVAR CAPITAL PARTNERS GROUP, LLC | $173 576 | 103 319 | 0,06% | Akcje |
| Bridgewater Associates, LP | $172 638 | 102 761 | 0,06% | Akcje |
| GABELLI FUNDS LLC | $168 000 | 100 000 | 0,06% | Akcje |
| CITADEL ADVISORS LLC | $152 964 | 91 050 | 0,06% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $142 506 | 84 825 | 0,05% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $134 324 | 79 955 | 0,05% | Akcje |
| NJ State Employees Deferred Compensation Plan | $128 000 | 100 000 | 0,05% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $126 573 | 75 341 | 0,05% | Akcje |
| HUB Investment Partners, LLC | $126 000 | 75 000 | 0,05% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $120 861 | 71 941 | 0,04% | Akcje |
| HARTLINE INVESTMENT CORP/ | $115 920 | 69 000 | 0,04% | Akcje |
| Cerity Partners LLC | $115 811 | 68 935 | 0,04% | Akcje |
| STIFEL FINANCIAL CORP | $114 659 | 68 249 | 0,04% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $113 249 | 67 410 | 0,04% | Akcje |
| SIMPLEX TRADING, LLC | $110 307 | 65 659 | 0,04% | Akcje |
| CITADEL ADVISORS LLC | $109 536 | 65 200 | 0,04% | Opcja sprzedaży |
| Nuveen, LLC | $99 117 | 58 998 | 0,04% | Akcje |
| VOYA INVESTMENT MANAGEMENT LLC | $96 004 | 57 145 | 0,03% | Akcje |
| CAPTRUST FINANCIAL ADVISORS | $94 854 | 56 461 | 0,03% | Akcje |
| Cetera Investment Advisers | $91 834 | 54 663 | 0,03% | Akcje |
| State of Wyoming | $91 169 | 54 267 | 0,03% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $86 972 | 51 769 | 0,03% | Akcje |
| Abacus Planning Group, Inc. | $86 080 | 51 238 | 0,03% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $85 770 | 54 981 | 0,03% | Akcje |
| Evolution Wealth Advisors, LLC | $84 000 | 50 000 | 0,03% | Akcje |
| China Universal Asset Management Co., Ltd. | $83 046 | 49 432 | 0,03% | Akcje |
Insiderzy spółki 30 insiderów · 6 dyrektorzy generalni · 11 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Mark Van Oene | President & CEO | 17 sierpnia 2026 S | 2 705 853 | 0 | 5 | $-370 277 |
| Susan K Barnes | EVP, CFO and PAO | 19 lutego 2020 S | 874 812 | 0 | 0 | $0 |
| James Michael Phillips | SVP, Research & Development | 24 marca 2020 S | 249 220 | 0 | 0 | $0 |
| Kevin P Corcoran | SVP, Market Development | 24 listopada 2017 M | 158 174 | 0 | 0 | $0 |
| Michael Glynn | Chief Commercial Officer | 15 lutego 2012 A | — | 0 | 0 | $0 |
| Stephen W Turner | VP & Chief Technology Officer | 11 lipca 2011 J | 1 093 063 | 0 | 0 | $0 |
| Christopher Gibson | Dyrektor | 3 czerwca 2026 A | 53 913 | 0 | 0 | $0 |
| Hannah Valantine | Dyrektor | 3 czerwca 2026 A | 22 821 | 0 | 0 | $0 |
| William W. Ericson | Dyrektor | 3 czerwca 2026 A | 41 616 | 0 | 0 | $0 |
| Christopher M Smith | Dyrektor | 3 czerwca 2026 A | 54 099 | 0 | 0 | $0 |
| Marshall Mohr | Dyrektor | 3 czerwca 2026 A | 132 821 | 0 | 0 | $0 |
| Randall S Livingston | Dyrektor | 3 czerwca 2026 A | 22 821 | 0 | 0 | $0 |
| Kathy Ordonez | Dyrektor | 3 czerwca 2026 A | 403 037 | 0 | 0 | $0 |
| John F Milligan | Dyrektor | 3 czerwca 2026 A | 132 821 | 0 | 0 | $0 |
| David B. Singer | Dyrektor | 13 czerwca 2012 A | — | 0 | 0 | $0 |
| Susan E Siegel | Dyrektor | 13 czerwca 2012 A | 65 000 | 0 | 0 | $0 |
| Hugh C Martin | Dyrektor | 3 lutego 2012 M | 342 458 | 0 | 0 | $0 |
| James R Gibson II | — | 1 kwietnia 2026 S | 1 245 663 | 0 | 1 | $-120 813 |
| Michele Farmer | — | 3 marca 2026 S | 305 948 | 0 | 3 | $-84 510 |
| Christian O Henry | — | 3 marca 2026 S | 3 581 813 | 0 | 3 | $-772 728 |
| Lucy Shapiro | — | 4 czerwca 2025 A | 22 821 | 0 | 0 | $0 |
| Susan G. Kim | — | 30 września 2024 S | 695 654 | 0 | 0 | $0 |
| Jeff Eidel | — | 19 sierpnia 2024 S | 869 730 | 0 | 0 | $0 |
| David W Meline | — | 18 czerwca 2024 A | 57 116 | 0 | 0 | $0 |
| David Botstein | — | 24 maja 2023 A | 0 | 0 | 0 | $0 |
| Peter Fromen | — | 2 marca 2022 A | 190 280 | 0 | 0 | $0 |
| Michael Hunkapiller | — | 26 lutego 2021 M | 848 405 | 0 | 0 | $0 |
| Eric Schaefer | — | 22 lutego 2021 S | 88 474 | 0 | 0 | $0 |
| BYERS BROOK H | — | 17 maja 2016 A | 110 504 | 0 | 0 | $0 |
| Brian B Dow | — | 2 marca 2015 P | 18 119 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, Alec N. Litowitz ×3 zgłoszenia | 29 sierpnia 2019 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 32 fundusze ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| ARKG · ARK ETF Trust | 1,41% | 10 964 895 NS | 30 kwietnia 2026 | N-PORT |
| EVNT · AltShares Trust | 0,75% | 62 040 NS | 31 maja 2026 | N-PORT |
| GNOM · Global X Funds | 0,40% | 151 435 NS | 31 maja 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,39% | 75 049 SH | 8 sierpnia 2026 | Dziennie |
| IDNA · iShares Trust | 0,37% | 622 048 SH | 8 sierpnia 2026 | Dziennie |
| ARKK · ARK ETF Trust | 0,36% | 14 733 201 NS | 30 kwietnia 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 1 067 027 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 280 941 SH | 8 sierpnia 2026 | Dziennie |
| IBB · iShares Trust | 0,03% | 2 125 671 SH | 8 sierpnia 2026 | Dziennie |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 16 737 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,02% | 11 163 NS | 31 maja 2026 | N-PORT |
| IWO · iShares Trust | 0,02% | 2 413 297 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 121 533 NS | 30 kwietnia 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 7 202 610 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,01% | 12 995 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3 579 782 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 1 624 029 SH | 8 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 727 094 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 1 434 895 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 10 163 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 10 278 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 9 612 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 258 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 206 229 SH | 8 sierpnia 2026 | Dziennie |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 174 278 NS | 31 maja 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 431 365 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 48 231 NS | 30 kwietnia 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 68 930 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9 535 565 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 17 047 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 22 805 SH | 8 sierpnia 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,00% | 8 144 NS | 30 kwietnia 2026 | N-PORT |